Tyra Biosciences (TYRA) Profit After Tax (2020 - 2026)
Tyra Biosciences (TYRA) posted Profit After Tax of -$39.6 million for Q1 2026, down 16.85% on a QoQ basis from -$33.9 million in Q4 2025, and down 40.66% year-over-year from -$66.7 million in Q1 2025.
Tyra Biosciences (TYRA) Profit After Tax (2020 - 2026) Analysis & Trends
Tyra Biosciences' Profit After Tax history runs 7 years deep, the most recent figure standing at -$39.6 million for Q1 2026.
- Quarterly Profit After Tax fell 40.66% year-over-year to -$39.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$131.4 million (down 37.65% YoY) and the FY2025 annual result came in at -$120.3 million, down 39.76% from the prior year.
- Profit After Tax was -$39.6 million for Q1 2026 at Tyra Biosciences, down from -$33.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$11.9 million in Q1 2023 and bottomed at -$39.6 million in Q1 2026.
- A 5-year average of -$21.7 million and a median of -$21.2 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 252.25% — and 2023, when it rose 19.87%.
- Tyra Biosciences' Profit After Tax stood at -$12.9 million in 2022, then slumped by 74.09% to -$22.4 million in 2023, then dropped by 18.28% to -$26.6 million in 2024, then decreased by 27.61% to -$33.9 million in 2025, then slipped by 16.85% to -$39.6 million in 2026.
- Business Quant data shows TYRA's Profit After Tax at -$39.6 million in Q1 2026, -$33.9 million in Q4 2025, and -$29.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | -39.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.59 Mn |
| Dec 31, 2025 | -33.88 Mn |
| Sep 30, 2025 | -29.86 Mn |
| Jun 30, 2025 | -28.10 Mn |
| Mar 31, 2025 | -28.15 Mn |
| Dec 31, 2024 | -26.55 Mn |
| Sep 30, 2024 | -22.08 Mn |
| Jun 30, 2024 | -18.70 Mn |
| Mar 31, 2024 | -18.19 Mn |
| Dec 31, 2023 | -22.45 Mn |
| Sep 30, 2023 | -21.15 Mn |
| Jun 30, 2023 | -13.27 Mn |
| Mar 31, 2023 | -11.88 Mn |
| Dec 31, 2022 | -12.90 Mn |
| Sep 30, 2022 | -12.51 Mn |
| Jun 30, 2022 | -15.10 Mn |
| Mar 31, 2022 | -14.83 Mn |
| Dec 31, 2021 | -9.93 Mn |
| Sep 30, 2021 | -6.64 Mn |
| Jun 30, 2021 | -5.51 Mn |